Inhaler with orientation sensor

1. An inhaler for oral delivery of medication, the inhaler comprising:

an actuation detector configured to provide an actuation signal in response to release of the medication from the inhaler;

an accelerometer configured to measure an orientation angle of the inhaler;

a processor coupled to the actuation detector and the accelerometer, wherein the processor is configured with processor-executable instructions to perform operations to:

determine whether the orientation angle of the inhaler measured by the accelerometer departs from a preferred orientation angle by an amount that exceeds a predetermined proper orientation threshold; and

determine a quality of use of the inhaler based on the actuation signal provided by the actuation detector and the orientation of the inhaler measured by the accelerometer, wherein the quality of use comprises an improper orientation angle in response to determining that the orientation angle of the inhaler departs from the preferred orientation angle by the amount that exceeds the predetermined proper orientation threshold;

an inhibiter configured to prevent the inhaler from dispensing the medication, wherein the inhibiter is a restrictive mechanical device that prevents the release of the medication from the inhaler, and wherein the processor is further configured with processor-executable instructions to activate the inhibiter based on the quality of use of the inhaler reflecting the improper orientation angle; and

an indicator configured to alert a user regarding the quality of use, wherein the alert comprises information about the determined improper orientation angle.

2. The inhaler of claim 1 , wherein the processor is further configured with processor-executable instructions to:

receive from the accelerometer an accelerometer measurement indicating movement information of the inhaler; and

determine whether the movement information is contextual information associated with activity performed by a user carrying the inhaler.

3. The inhaler of claim 2 , wherein the contextual information includes a predetermined type of activity by the user.

4. The inhaler of claim 1 , wherein the processor is further configured with processor-executable instructions to perform operations to:

determine an activation duration based on a total period in which the medication is released; and

determine an improper usage duration, wherein the improper usage duration is a period during the activation duration in which the orientation angle of the inhaler deviates from the preferred orientation angle by an amount that exceeds a predetermined proper orientation threshold, wherein determining the quality of use of the inhaler includes discounting the activation duration by the improper usage duration.

5. The inhaler of claim 1 , wherein the processor is further configured with processor-executable instructions to perform operations to:

determine whether the inhaler has been agitated a predetermined amount, wherein the quality of use reflects an improper agitation in response to determining that the inhaler has not been agitated the predetermined amount before the medication is released.

6. The inhaler of claim 1 , further comprising:

a wireless signal transmitter coupled to the processor, wherein the wireless signal transmitter is configured to transmit data to a computing device remote from the inhaler to enable the computing device to determine the quality of use of the inhaler.

7. The inhaler of claim 1 , further comprising:

a memory coupled to the processor and configured to store data indicating the quality of use of the inhaler.

8. The method of claim 1 , wherein the processor is further configured with processor-executable instructions to activate the indicator based on the quality of use of the inhaler determined.